Infertility affects 10.7–15.5% of couples worldwide, and it is defined as the inability to conceive after 6–12 months of unprotected sexual intercourse [1]. Reproductive medicine is a fast-moving field whose ultimate goal is to provide people with better reproductive choices. Since the first human in vitro fertilization (IVF) assay [2, 3] and the first IVF pregnancies and children [4, 5], the demographic of individuals conceived through assisted reproductive technologies (ART) has been rapidly rising, getting close today to a 0.1% of the global human population [6]. ART includes medical procedures that involve the in vitro handling of gametes or preimplantation embryos to achieve pregnancy in patients seeking medical assistance.
Many research and clinical groups worldwide use various approaches to study, prevent, diagnose and treat reproductive disorders [7]. These tremendous research efforts have led to the development of several techniques regularly used today by fertility specialists. Although very diverse in nature, all these technologies share an essential commonality: their relevance to improving interventions and treatments in reproductive medicine. Since the seminal discovery of Intracytoplasmic Sperm Injection (ICSI) in 1992 [8], significant research efforts have focused on improving ART procedure outcomes. Examples include optimizing follicular stimulation protocols to obtain a sufficient number of quality ovulated metaphase II (MII) oocytes while preventing ovarian hyperstimulation syndrome [9]. Other examples are developing appropriate sperm selection strategies for patients requiring ICSI [10] and culture media and conditions to improve embryo development and maximize blastocyst formation [11] and embryo transfer for successful implantation [12]. In addition, for over two decades, preimplantation genetic testing (PGT) for aneuploidy (PGT-A) has been adopted to reduce the risk of miscarriage [13,14,15]. In addition, PGT for monogenic (PGT-M) or polygenic disorders (PGT-P) have been used to prevent the conception of embryos potentially affected by genetic diseases [16, 17].
Also, further advancements in computer and information sciences have been contributing to providing more targeted treatments in reproductive medicine [18], which include the selection of sperm [19] or blastocysts for embryo transfer [20]. At the same time, with the advent of Next Generation Sequencing tools and precise genome editing technologies, the genetics of infertility field has expanded significantly. Several studies have functionally characterized DNA variants affecting different aspects of human reproductive biology, which include sex determination, oogenesis and spermatogenesis, fertilization, and preimplantation embryo development [21,22,23,24]. The improved knowledge of aberrant mechanisms offers the promise of novel, effective and implementable medical interventions in the future [25, 26]. Moreover, although ART was initially designed to treat fertility disorders, as of today, these technologies are often used to provide patients with a diverse plethora of reproductive choices. For example, ART offers different fertility preservation options (e.g., gamete or embryo cryopreservation, ovarian tissue cryopreservation) in patients with the risk of gonadal failure due to chemotherapy or radiotherapy treatments [27].
We are delighted to launch a new section in the Journal of Translational Medicine named “Reproductive Medicine & Clinical Reproductive Sciences”. This section welcomes new research focusing on the basic mechanisms or the translational and clinical aspects of human reproductive biology. Also, we encourage the submission of preclinical and clinical studies whose results have the potential to prevent, diagnose, and treat reproductive issues, as well as studies that describe and characterize the genes and the mechanisms regulating human reproductive biology in cell lines or animal models. Reviews on existing and novel technologies, and commentaries on scientific breakthroughs in the field are also welcome. We look forward to receiving your contributions.
References
Thoma ME, McLain AC, Louis JF, King RB, Trumble AC, Sundaram R, et al. Prevalence of infertility in the United States as estimated by the current duration approach and a traditional constructed approach. Fertil Steril. 2013;99:1324–31.
Edwards R, Bavister B, Steptoe P. Did fertilization occur? Nature. 1969;221:981–2.
Edwards RG, Steptoe PC, Purdy JM. Fertilization and cleavage in vitro of preovulator human oocytes. Nature. 1970;227:1307–9.
Jones HW, Jones GS, Andrews MC, Acosta A, Bundren C, Garcia J, et al. The program for in vitro fertilization at Norfolk. Fertil Steril. 1982;38:14–21.
Steptoe PC, Edwards RG, Purdy JM. Clinical aspects of pregnancies established with cleaving embryos grown in vitro. Br J Obstet Gynaecol. 1980;87:757–68.
Faddy MJ, Gosden MD, Gosden RG. A demographic projection of the contribution of assisted reproductive technologies to world population growth. Reprod Biomed Online Elsevier. 2018;36:455–8.
Farquhar C, Marjoribanks J. Assisted reproductive technology: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2018;8:CD010537.
Palermo G, Joris H, Devroey P, Van Steirteghem AC. Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet Lond Engl. 1992;340:17–8.
Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org, Practice Committee of the American Society for Reproductive Medicine. Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline. Fertil Steril. 2016;106:1634–47.
Leung ETY, Lee C-L, Tian X, Lam KKW, Li RHW, Ng EHY, et al. Simulating nature in sperm selection for assisted reproduction. Nat Rev Urol. 2022;19:16–36.
Anderson M, Han T, Liebermann J, Tucker M. Extended embryo culture: use of two media simultaneously is an optimal approach to maximize blastocyst formation and utilization. Fertil Steril. 2002;78:253–4.
Saravelos SH, Li T-C. Embryo transfer techniques. Best Pract Res Clin Obstet Gynaecol. 2019;59:77–88.
Rubio C, Bellver J, Rodrigo L, Castillón G, Guillén A, Vidal C, et al. In vitro fertilization with preimplantation genetic diagnosis for aneuploidies in advanced maternal age: a randomized, controlled study. Fertil Steril. 2017;107:1122–9.
Scott RT, Ferry K, Su J, Tao X, Scott K, Treff NR. Comprehensive chromosome screening is highly predictive of the reproductive potential of human embryos: a prospective, blinded, nonselection study. Fertil Steril. 2012;97:870–5.
Cariati F, D’Argenio V, Tomaiuolo R. The evolving role of genetic tests in reproductive medicine. J Transl Med. 2019;17:267.
Zimmerman RS, Jalas C, Tao X, Fedick AM, Kim JG, Pepe RJ, et al. Development and validation of concurrent preimplantation genetic diagnosis for single gene disorders and comprehensive chromosomal aneuploidy screening without whole genome amplification. Fertil Steril. 2016;105:286–94.
Treff NR, Zimmerman R, Bechor E, Hsu J, Rana B, Jensen J, et al. Validation of concurrent preimplantation genetic testing for polygenic and monogenic disorders, structural rearrangements, and whole and segmental chromosome aneuploidy with a single universal platform. Eur J Med Genet. 2019;62:103647.
Hajirasouliha I, Elemento O. Precision medicine and artificial intelligence: overview and relevance to reproductive medicine. Fertil Steril. 2020;114:908–13.
You JB, McCallum C, Wang Y, Riordon J, Nosrati R, Sinton D. Machine learning for sperm selection. Nat Rev Urol. 2021;18:387–403.
Khosravi P, Kazemi E, Zhan Q, Malmsten JE, Toschi M, Zisimopoulos P, et al. Deep learning enables robust assessment and selection of human blastocysts after in vitro fertilization. Npj Digit Med. 2019;2:1–9.
Bhakta HH, Refai FH, Avella MA. The molecular mechanisms mediating mammalian fertilization. Development. 2019;146:dev176966.
Greer C, Bhakta H, Ghanem L, Refai F, Linn E, Avella M. Deleterious variants in genes regulating mammalian reproduction in neanderthals, denisovans and extant humans. Hum Reprod Oxf Engl. 2021;36:734–55.
Fakhro KA, Elbardisi H, Arafa M, Robay A, Rodriguez-Flores JL, Al-Shakaki A, et al. Point-of-care whole-exome sequencing of idiopathic male infertility. Genet Med Off J Am Coll Med Genet. 2018;20:1365–73.
Jiao S-Y, Yang Y-H, Chen S-R. Molecular genetics of infertility: loss-of-function mutations in humans and corresponding knockout/mutated mice. Hum Reprod Update. 2021;27:154–89.
Avella MA, Baibakov BA, Jimenez-Movilla M, Sadusky AB, Dean J. ZP2 peptide beads select human sperm in vitro, decoy mouse sperm in vivo, and provide reversible contraception. Sci Transl Med. 2016;8:336ra60.
Miller D, Pavitt S, Sharma V, Forbes G, Hooper R, Bhattacharya S, et al. Physiological, hyaluronan-selected intracytoplasmic sperm injection for infertility treatment (HABSelect): a parallel, two-group, randomised trial. Lancet Lond Engl. 2019;393:416–22.
Fisch B, Abir R. Female fertility preservation: past, present and future. Reprod Camb Engl. 2018;156:F11–27.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Choucair, F., Avella, M. Basic, translational and clinical studies in reproductive medicine and clinical reproductive sciences. J Transl Med 21, 534 (2023). https://doi.org/10.1186/s12967-023-04108-4
Published:
DOI: https://doi.org/10.1186/s12967-023-04108-4